IRVINE, CA--(BUSINESS WIRE)--Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), today announced that the HairDX genetic test collection kit for baldness is now listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and the United States Food and Drug Administration (FDA) as a Class I medical device.
